Anbio Biotechnology Class A Ordinary Shares Financials

Values in thousands	2025-06-30	2024-12-31	2024-06-30	2023-12-31
Revenue	$5,007	$2,528	$6,322	$3,950
Gross Profit	4,622	2,137	4,226	1,691
EBITDA	4,148	-1,324	3,887	796
EBIT		-1,735	3,889	792
Net Income	4,148	-1,324	3,887	792
Net Change In Cash	5,007	2,528	6,322	3,950
Free Cash Flow		1,604	647	-1,331
Cash	6,278	11,760	10,310	9,687
Basic Shares	43,891	42,291	42,291	42,291

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$8,185	$6,711	$23,544	$4,428
Gross Profit	5,885	3,360	12,563	2,541
EBITDA	2,566	2,266	10,025	2,535
EBIT	1,995	2,253	10,019	2,455
Net Income	2,372	2,253	10,011	2,535
Net Change In Cash	8,185	6,711	23,544	4,428
Free Cash Flow	2,080	898	4,448	4,181
Cash	11,760	9,687	7,102	4,181
Basic Shares	42,291	187,782	143,891	100,000